(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $1936.94 | $1940.46 | $1510.71 | |
Short term investments | ||||
Net receivables | $25955.51 | $24112.69 | $25024.76 | |
Inventory | $1312.58 | $1369.24 | $1475.06 | |
Total current assets | $64472.11 | $68948.37 | $74339.65 | |
Long term investments | ||||
Property, plant & equipment | $85320.6 | $87135.24 | $88177.95 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $276525.64 | $283447.6 | $289772.03 | |
Current liabilities | ||||
Accounts payable | $15600.82 | $16112.75 | $17554.78 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $38224.85 | $38796.26 | $31235.49 | |
Long term debt | $86972.33 | $91883.28 | $105605.16 | |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $150092.84 | $155807.86 | $161888.59 | |
Shareholders' equity | ||||
Retained earnings | $126815.36 | $127670.67 | $130496.08 | |
Other shareholder equity | $6665.35 | $7030.35 | $6107.38 | |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $2041.88 | $25593.3 | $29169 | |
Short term investments | $196.6 | |||
Net receivables | $26136.56 | $31934 | $27538.89 | |
Inventory | $1448.28 | $2212.9 | $1641.3 | |
Total current assets | $81533.7 | $72958.7 | $69518.86 | |
Long term investments | $32780.3 | $29787.55 | ||
Property, plant & equipment | $88906.7 | $95526.6 | $90496.52 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $9495.67 | |||
Total investments | ||||
Total assets | $297705.07 | $292900.5 | $271985.19 | |
Current liabilities | ||||
Accounts payable | $23952.58 | $22670.6 | $21973.21 | |
Deferred revenue | ||||
Short long term debt | $4106.4 | $616.99 | ||
Total current liabilities | $34696.95 | $56498.6 | $44038.68 | |
Long term debt | $111236.49 | $121685.7 | $121935.98 | |
Total noncurrent liabilities | $6548.93 | |||
Total debt | $6630.32 | |||
Total liabilities | $170932.66 | $197113.8 | $183674.6 | |
Shareholders' equity | ||||
Retained earnings | $129492.92 | $87548.9 | $84638.41 | |
Other shareholder equity | -$10798.48 | -$13582.8 | -$13107.78 | |
Total shareholder equity | $80487.5 | $73800.48 |
(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $18412.41 | $18520.23 | $18519.63 | |
Cost of revenue | ||||
Gross Profit | $6133.74 | $6396.43 | $6437.66 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $5617.79 | $5349.38 | $5207.02 | |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1560.38 | $93.08 | -$187.97 | |
Interest expense | -$8006.65 | -$726.69 | -$2101.82 | |
Net income | ||||
Net income | -$8661.95 | $133.47 | -$788.86 | |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $73767.93 | $75526.61 | $103521.8 | $97361.63 |
Cost of revenue | $59561.5 | $56989.65 | ||
Gross Profit | $24874.28 | $26719 | $43960.3 | $40371.98 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $24171 | $23080.24 | ||
Total operating expenses | $21230.19 | $21982.32 | $81338.5 | $79581.36 |
Operating income | $22183.3 | $17780.28 | ||
Income from continuing operations | ||||
EBIT | $22183.3 | $17780.28 | ||
Income tax expense | $2440.87 | -$967.38 | $7493.9 | $5004.66 |
Interest expense | -$10834.36 | -$17648.58 | -$12290.2 | -$10482.17 |
Net income | ||||
Net income | -$10235.87 | $43151.24 | $5386.5 | -$892.33 |
Income (for common shares) | $5386.5 | -$892.33 |
(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$15758.4 | -$11532 | -$7969.42 | -$3931 |
Financing activities | ||||
Dividends paid | -$1027.35 | -$1027.35 | -$1027.35 | |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$17666.92 | -$15522.99 | -$7488.29 | -$3807.26 |
Effect of exchange rate | -$234.64 | -$147.92 | -$169.2 | -$104.44 |
Change in cash and equivalents | -$18544.64 | -$18442.85 | -$12227.69 | -$7581.48 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Net income | $5386.5 | -$892.33 | ||
Operating activities | ||||
Depreciation | $21260.79 | |||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $33274.83 | |||
Investing activities | ||||
Capital expenditures | -$20132 | |||
Investments | $2678.8 | |||
Total cash flows from investing | -$15758.4 | $48295.91 | -$15637.04 | |
Financing activities | ||||
Dividends paid | -$1027.35 | -$1053.39 | -$66.62 | |
Sale and purchase of stock | ||||
Net borrowings | -$4864.54 | |||
Total cash flows from financing | -$17666.92 | -$29769.12 | -$15909.55 | |
Effect of exchange rate | -$234.64 | -$100.34 | -$11.52 | |
Change in cash and equivalents | -$18544.64 | $25302.78 | $1716.73 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | -3.76% |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |